Atlas Trials

Characterization of the Effects of Prolonged-release Fampridine on Ambulatory Function in Patients With Multiple Sclerosis

Clinical trial NCT01576354 · UNKNOWN

Trial details

NCT number
NCT01576354
Sponsor
University of Zurich
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Sclerosis
Start date
2012-03-01
Primary completion
2017-04-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.